Gaps in Treatment Among Users of Osteoporosis Medications: The Dynamics of Noncompliance M. Alan Brookhart, PhD, Jerry Avorn, MD, Jeffrey N. Katz, MD, MS, Joel S. Finkelstein, MD, Marilyn Arnold, ScD, Jennifer M. Polinski, MPH, Amanda R. Patrick, MS, Helen Mogun, MS, Daniel H. Solmon, MD, MPH The American Journal of Medicine Volume 120, Issue 3, Pages 251-256 (March 2007) DOI: 10.1016/j.amjmed.2006.03.029 Copyright © 2007 Elsevier Inc. Terms and Conditions
Figure 1 Diagram of case-crossover analysis of events predicting a return to medication use. The shaded area represents time when patient is on medication. The American Journal of Medicine 2007 120, 251-256DOI: (10.1016/j.amjmed.2006.03.029) Copyright © 2007 Elsevier Inc. Terms and Conditions
Figure 2 Kaplan-Meier estimate of the cumulative probability of returning to treatment. The American Journal of Medicine 2007 120, 251-256DOI: (10.1016/j.amjmed.2006.03.029) Copyright © 2007 Elsevier Inc. Terms and Conditions
Figure 3 Kaplan-Meier estimate of the cumulative probability of returning to treatment (stratified by length of time on medication before interruption). The American Journal of Medicine 2007 120, 251-256DOI: (10.1016/j.amjmed.2006.03.029) Copyright © 2007 Elsevier Inc. Terms and Conditions